Jesús H. González-Cortés, Departamento de Oftalmología, Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
Hugo A. Treviño-Rodríguez, Departamento de Oftalmología, Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
Jesús E. González-Cantú, Departamento BP. Invest, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
Jesús M.-Hamsho, Departamento de Oftalmología, Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México

Background: Idiopathic macular holes (IMH) are common and affect central vision. We demonstrate the effectiveness of 0.2 ml intravitreal perfluoropropane (C3F8) in Stage-2 IMH. Case: A 61-year-old woman presented with blurred vision OD. Best-corrected visual acuity (BCVA) was 20/125 OD and 20/20 OS. Biomicroscopy of OD evidenced a Stage-2 IMH. Intravitreal C3F8 was injected and postural measures prescribed. Optical coherence tomography 1 week after revealed posterior vitreous detachment and vitreomacular traction resolution. Full anatomical and functional recovery was achieved at week 4 and remained stable during a 6-month follow-up (BCVA 20/20 OD). Conclusion: Intravitreal C3F8 as initial therapy for Stage 2 IMH represents a good alternative to vitrectomy for patients with IMH.

Palabras clave: Idiopathic macular hole. Vitreomacular traction. Intravitreal inert gas. Anatomical closure.